VI
VI4.F Varex Imaging Corporation
- Market cap
- EUR 692M
- P/E
- 36.2x
- P/B
- 1.58x
- ROE
- 2.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.
Is VI4.F undervalued?
Graham numberVI4.F trades 59.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Varex Imaging Corporation fundamental analysis
No fundamental analysis for Varex Imaging Corporation yet.
Varex Imaging Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Varex Imaging Corporation
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure co…
Full company profileVarex Imaging Corporation financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Varex Imaging Corporation annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | 698M | 773M | 781M | 738M | 818M | 859M | 893M | 811M | 845M | 848M |
| Gross Profit | - | 254M | 254M | 257M | 190M | 272M | 284M | 290M | 257M | 291M | 292M |
| Operating Income | - | 83.7M | 44.5M | 50.5M | -30.9M | 74.1M | 88.2M | 77.1M | 32.1M | 66.1M | 70.1M |
| EBITDA | - | 115M | 89.6M | 81.8M | -1.70M | 70.7M | 84.3M | 91.2M | 62.9M | 700K | 72.8M |
| Net Income | - | 51.6M | 27.5M | 15.5M | -57.9M | 17.4M | 30.3M | 47.4M | -48.8M | -70.3M | 13.2M |
| EPS | - | 1.37 | 0.72 | 0.40 | -1.48 | 0.44 | 0.76 | 1.17 | -1.19 | -1.69 | 0.31 |
| Balance Sheet | |||||||||||
| Total Assets | - | 1.04B | 988M | 1.04B | 1.14B | 1.15B | 1.18B | 1.25B | 1.22B | 1.11B | 1.10B |
| Total Liabilities | - | 661M | 560M | 591M | 674M | 651M | 638M | 669M | 668M | 621M | 590M |
| Shareholders' Equity | - | 379M | 426M | 445M | 452M | 483M | 533M | 568M | 535M | 473M | 497M |
| Cash & Short-term Investments | - | 83.3M | 51.9M | 29.9M | 101M | 145M | 89.4M | 153M | 169M | 145M | 99.2M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 74.2M | 75.2M | 85.3M | 71.9M | 13.2M | 92.6M | 16.9M | 108M | 47.3M | 41.7M | 4.53M |
| Capital Expenditure | 0.00 | 20.2M | 20.4M | 19.8M | 23.5M | 15.1M | 21.3M | 20.7M | 26.9M | 22.9M | 34.5M |
| Free Cash Flow | - | 54.4M | 64.9M | 52.1M | -10.3M | 77.5M | -4.40M | 87.7M | 20.4M | 18.8M | -30.0M |
| Ratios | |||||||||||
| ROE | - | 13.6% | 6.5% | 3.5% | -12.8% | 3.6% | 5.7% | 8.3% | -9.1% | -14.9% | 2.7% |
| ROA | - | 5.0% | 2.8% | 1.5% | -5.1% | 1.5% | 2.6% | 3.8% | -4.0% | -6.3% | 1.2% |
| Net Profit Margin | - | 7.4% | 3.6% | 2.0% | -7.8% | 2.1% | 3.5% | 5.3% | -6.0% | -8.3% | 1.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Varex Imaging Corporation dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | EUR 227M | 6.03 | 440.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Varex Imaging Corporation
- Insiders 2.65%
- Institutions 89.89%
- Public & others 7.46%
- Shares outstanding 42.5M
- Free float 41.4M
Varex Imaging Corporation company profile
- Company name
- Varex Imaging Corporation
- Ticker
- VI4.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 2,500
- Fiscal year end
- September
- Address
- 1678 S. Pioneer Road, Salt Lake City, UT, United States, 84104
- Phone
- 801 972 5000
- Website
- vareximaging.com
About Varex Imaging Corporation
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
Varex Imaging Corporation management
10- Mr. Sunny S. SanyalPresident, CEO & Director · born 1964
- Mr. Shubham MaheshwariCFO & Principal Accounting Officer · born 1971
- Ms. Kimberley E. Honeysett J.D.Advisor · born 1970
- Mr. Mark S. JonaitisSenior VP & GM of X-Ray Sources · born 1962
- Mr. Andrew J. HartmannSenior VP & GM of X-Ray Detectors · born 1963
- Mr. Matthew A. MartinezChief Legal Officer & Corporate Secretary · born 1982
- Mr. Wouter VlaanderenVice President of Global Marketing
- Ms. Karen ArankiChief Human Resources Officer · born 1975
- Mr. Victor Hugo GarciaSenior Vice President of Regulatory & Quality Compliance
- Mr. Shaohua LiangVP & MD of China